KIORA PHARMACEUTICALS, INC. (KPRX) Operating cash flow 2016–2025
KIORA PHARMACEUTICALS, INC. (KPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.0MFY2025 · since FY2016: -$8.4M → -$10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.0M | -216.4% |
| FY2024 | $8.6M | +189.6% |
| FY2023 | -$9.6M | +8.4% |
| FY2022 | -$10.4M | +2.3% |
| FY2021 | -$10.7M | -45.9% |
| FY2020 | -$7.3M | +10.3% |
| FY2019 | -$8.2M | +24.8% |
| FY2018 | -$10.8M | -67.7% |
| FY2017 | -$6.5M | +23.1% |
| FY2016 | -$8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KPRX financial trends
KPRX RevenueKPRX Net incomeKPRX Net marginKPRX Gross profitKPRX Gross marginKPRX Operating incomeKPRX Operating marginKPRX Free cash flowKPRX Capital expendituresKPRX Return on equityKPRX Stock buybacksKPRX Dividends paidKPRX Total assetsKPRX Total liabilitiesKPRX Shareholders’ equityKPRX overview →